Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial.
Front Pharmacol
; 14: 1172483, 2023.
Article
in En
| MEDLINE
| ID: mdl-37214431
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
Front Pharmacol
Year:
2023
Document type:
Article
Affiliation country: